Meet the OBR Editorial Board

Editor's Note: At OBR we have created an editorial board of renown thought leaders in different cancer disease areas. The role of our editorial board is to provide valuable insights through editorial commentary accompanying our daily news. We call it virtual access. By providing our insights into the daily news, you will have access into how these thought leading oncologists interpret the oncology news and events we carry in OBR daily. We hope that our editorial boards's insights will bring great value to the oncology community.

View all Editorial Board Member Commentary

Browse Editors by Section

member-photo

Debu Tripathy, MD

Professor and Chair, Department of Breast Medical Oncology
The University of Texas MD Anderson Cancer Center

Comments

FDA Approves Trodelvy®, the First Treatment for Metastatic Triple-Negative Breast Cancer Shown to Improve Progression-Free Survival and Overall Survival

quotesThese are dramatic results not seen previously in any randomized trial for triple negative breast ca…quotes

member-photo

Howard S. Hochster, MD

Distinguished Professor of Medicine, Rutgers Robert Wood Johnson Medical School
Rutgers-CINJ Associate Director, Clinical Research
Director Clinical Oncology Research, RWJ-B Health System

Comments

FDA Approves New Dosing Regimen For Cetuximab

quotes"UPDATE": I am glad the FDA caught up with itself. The dosing regimen for Cetuximab was approved b…quotes

member-photo

Ted Okon

Executive Director
Community Oncology Alliance

Comments

Oncologists Remind America: Time To Get Cancer Screenings Back On Track

quotesOne of the scariest "under" stories of COVID-19 is the impact on cancer screenings. With screenings …quotes

member-photo

William McGivney, PhD

National Health Policy Expert

Comments

First Opinion: The Biden Administration Needs to Look Beyond ICER for Evaluating Drug Therapies

quotesIt is extremely disconcerting to think that ICER could be thought of as possibly playing a significa…quotes

member-photo

Tomasz M. Beer, MD, FACP

Professor of Medicine, Division of Hematology/Medical Oncology, School of Medicine
Grover C. Bagby Chair of Prostate Cancer Research
OHSU Knight Cancer Institute Deputy Director, OHSU Knight Cancer Institute, School of Medicine
Chief Medical Officer, CEDAR, OHSU Knight Cancer Institute, School of Medicine

Comments

2021 GU Cancers Symposium: Apalutamide Combo Boosts PFS in ACIS Trial of mCRPC

quotesThis study demonstrated an improvement in progression-free survival but not overall survival with in…quotes

member-photo

Tomasz M. Beer, MD, FACP

Professor of Medicine, Division of Hematology/Medical Oncology, School of Medicine
Grover C. Bagby Chair of Prostate Cancer Research
OHSU Knight Cancer Institute Deputy Director, OHSU Knight Cancer Institute, School of Medicine
Chief Medical Officer, CEDAR, OHSU Knight Cancer Institute, School of Medicine

Comments

2021 GU Cancers Symposium: Apalutamide Combo Boosts PFS in ACIS Trial of mCRPC

quotesThis study demonstrated an improvement in progression-free survival but not overall survival with in…quotes

member-photo

Dean Gesme, MD

FACP FACPE FASCO
President, Minnesota Oncology

Comments

Boston Scientific Receives FDA Approval for TheraSphere™ Y-90 Glass Microspheres

quotesWe now have two FDA approved Y-90 microspheres with very similar properties for use as liver directe…quotes

member-photo

Debu Tripathy, MD

Professor and Chair, Department of Breast Medical Oncology
The University of Texas MD Anderson Cancer Center

Comments

FDA Approves Trodelvy®, the First Treatment for Metastatic Triple-Negative Breast Cancer Shown to Improve Progression-Free Survival and Overall Survival

quotesThese are dramatic results not seen previously in any randomized trial for triple negative breast ca…quotes

member-photo

H. Jack West, MD

Associate Clinical Professor, Medical Oncology
Executive Director, Employer Services
City of Hope Comprehensive Cancer Center
Duarte, CA

Comments

Immune-boosting Drug May Help Before Lung Cancer Surgery

quotesThese data are extremely encouraging for this setting, with a remarkable increase in the rate of pat…quotes

member-photo

Howard S. Hochster, MD

Distinguished Professor of Medicine, Rutgers Robert Wood Johnson Medical School
Rutgers-CINJ Associate Director, Clinical Research
Director Clinical Oncology Research, RWJ-B Health System

Comments

FDA Approves New Dosing Regimen For Cetuximab

quotes"UPDATE": I am glad the FDA caught up with itself. The dosing regimen for Cetuximab was approved b…quotes

member-photo

Howard Sandler, MD, MS, FASTRO

Ronald H. Bloom Chair in Cancer Therapeutics
Professor and Chair, Department of Radiation Oncology
Interim Director, Samuel Oschin Comprehensive Cancer Institute
Cedars-Sinai Medical Center

Comments

New Scan Finds Prostate Cancer Cells Hiding in the Body

quotesCan't emphasize how important the PSMA PET scan will be in the routine management of prostate cancer…quotes

member-photo

Robert A. Figlin, MD., FACP

Steven Spielberg Family Chair in Hematology Oncology
Professor of Medicine and Biomedical Sciences
Deputy Director, Cedars-Sinai Cancer
Deputy Director, Samuel Oschin Comprehensive Cancer Institute
Cedars-Sinai Medical Center

Comments

CT Scans Can Reduce Lung Cancer Deaths, Study Finds

quotesThis long awaited trial performed by the National Cancer Institute demonstrates the benefits of low …quotes

member-photo

Stephen M. Schleicher, M.D., MBA

Community Oncology,
Medical Oncologist,
OneOncology

Comments

Eligible Clinicians Will Not Face Payment Penalties for MIPS Performance in 2020

quotesSimilar to CMS's flexibility with two sided risk in OCM and delay of OCF, this is yet another exampl…quotes

member-photo

Ted Okon

Executive Director
Community Oncology Alliance

Comments

Oncologists Remind America: Time To Get Cancer Screenings Back On Track

quotesOne of the scariest "under" stories of COVID-19 is the impact on cancer screenings. With screenings …quotes

member-photo

Thomas Marsland, MD

Vice President
Integrated Community Oncology Network
Former Community Representative
ASCO Board of Directors

Comments

Opinion: The Drugs at the Heart of Our Pricing Crisis

quotesHaving just gotten out of a "virtual" CPC meeting where drug cost and pricing were discussed, and ha…quotes

member-photo

William McGivney, PhD

National Health Policy Expert

Comments

First Opinion: The Biden Administration Needs to Look Beyond ICER for Evaluating Drug Therapies

quotesIt is extremely disconcerting to think that ICER could be thought of as possibly playing a significa…quotes

member-photo

H. Jack West, MD

Associate Clinical Professor, Medical Oncology
Executive Director, Employer Services
City of Hope Comprehensive Cancer Center
Duarte, CA

Comments

Immune-boosting Drug May Help Before Lung Cancer Surgery

quotesThese data are extremely encouraging for this setting, with a remarkable increase in the rate of pat…quotes

member-photo

Robert A. Figlin, MD., FACP

Steven Spielberg Family Chair in Hematology Oncology
Professor of Medicine and Biomedical Sciences
Deputy Director, Cedars-Sinai Cancer
Deputy Director, Samuel Oschin Comprehensive Cancer Institute
Cedars-Sinai Medical Center

Comments

CT Scans Can Reduce Lung Cancer Deaths, Study Finds

quotesThis long awaited trial performed by the National Cancer Institute demonstrates the benefits of low …quotes

member-photo

Dean Gesme, MD

FACP FACPE FASCO
President, Minnesota Oncology

Comments

Boston Scientific Receives FDA Approval for TheraSphere™ Y-90 Glass Microspheres

quotesWe now have two FDA approved Y-90 microspheres with very similar properties for use as liver directe…quotes

member-photo

Thomas Marsland, MD

Vice President
Integrated Community Oncology Network
Former Community Representative
ASCO Board of Directors

Comments

Opinion: The Drugs at the Heart of Our Pricing Crisis

quotesHaving just gotten out of a "virtual" CPC meeting where drug cost and pricing were discussed, and ha…quotes

member-photo

Howard Sandler, MD, MS, FASTRO

Ronald H. Bloom Chair in Cancer Therapeutics
Professor and Chair, Department of Radiation Oncology
Interim Director, Samuel Oschin Comprehensive Cancer Institute
Cedars-Sinai Medical Center

Comments

New Scan Finds Prostate Cancer Cells Hiding in the Body

quotesCan't emphasize how important the PSMA PET scan will be in the routine management of prostate cancer…quotes